Prices delayed by at least 15 minutes | Print
Trinity Biotech plc (TRIB)
American Depository ReceiptThis share can be held in a Dealing accountSIPP
Company profile
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Address
IDA Business Park
Bray, Wicklow
Dublin
IRL
Telephone
+353 1 2769800
Forecast key dates
| Name | Key Date |
|---|---|
| Trinity Biotech PLC Fourth Quarter Earnings Conference Call for 2024 | 2025-04-04T08:00:00 |
| Trinity Biotech PLC Fourth Quarter Earnings Results for 2024 | 2025-04-04T00:00:00 |
| Trinity Biotech PLC Third Quarter Earnings Conference Call for 2024 | 2025-01-31T08:30:00 |
| Trinity Biotech PLC Third Quarter Earnings Results for 2024 | 2025-01-31T00:00:00 |
| Trinity Biotech PLC Second Quarter Earnings Conference Call for 2024 | 2024-10-03T11:00:00 |
| Trinity Biotech PLC Second Quarter Earnings Results for 2024 | 2024-10-03T00:00:00 |
| Trinity Biotech PLC Annual General Meeting for 2024 | 2024-09-27T10:00:00 |
| Trinity Biotech PLC First Quarter Earnings Conference Call for 2024 | 2024-07-05T11:00:00 |
| Trinity Biotech PLC First Quarter Earnings Results for 2024 | 2024-07-05T00:00:00 |
| Trinity Biotech PLC Annual Report for 2023 | 2024-05-16T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Trinity Biotech PLC Annual Report for 2023 | 2024-05-16T00:00:00 |
| Trinity Biotech PLC Fourth Quarter Earnings Conference Call for 2023 | 2024-04-04T08:00:00 |
| Trinity Biotech PLC Fourth Quarter Earnings Result for 2023 | 2024-04-04T00:00:00 |
| Trinity Biotech PLC Emerging Growth Conference | 2024-03-07T11:25:00 |
| Trinity Biotech PLC Third Quarter Earnings Conference Call for 2023 | 2024-01-31T08:30:00 |
| Trinity Biotech PLC Third Quarter Earnings Result for 2023 | 2024-01-31T00:00:00 |
| Trinity Biotech PLC Second Quarter Earnings Conference Call for 2023 | 2023-10-03T11:00:00 |
| Trinity Biotech PLC Second Quarter Earnings Result for 2023 | 2023-10-03T00:00:00 |
| Trinity Biotech PLC Annual General Meeting for 2023 | 2023-09-29T10:00:00 |
| Trinity Biotech PLC First Quarter Earnings Conference Call for 2023 | 2023-07-06T11:00:00 |
| Trinity Biotech PLC First Quarter Earnings Result for 2023 | 2023-07-06T00:00:00 |
| Trinity Biotech PLC Annual Report for 2022 | 2023-05-16T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.